13F-HR filed by Venrock Adviser, LLC
Venrock Adviser, LLC filed this 13F-HR for the quarter ended 2020-06-30, filed 2020-08-14, with 16 holding rows worth $417,632,000.
- Accession
- 0001104659-20-095569
- Filer
- CIK 1615982
- Filed
- 2020-08-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2020
A holdings report, 16 entries on the cover page, a total value of $417,632,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $417,632,000 with VALUE read as thousands by filing date, 13F file number 028-20281. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| CONSTELLATION PHARMACEUTICALS INC. | 210373106 | Common Stock | 4,016,873 | $120,707,000 | thousands by filing date | |
| TRILLIUM THERAPEUTICS INC COM NEW | 89620X506 | Stock | 6,790,000 | $54,931,000 | thousands by filing date | |
| ALTIMMUNE INC | 02155H200 | COM NEW | 4,500,000 | $48,195,000 | thousands by filing date | |
| RELMADA THERAPEUTICS INC | 75955J402 | COMMON STOCK | 668,440 | $29,913,000 | thousands by filing date | |
| SURFACE ONCOLOGY INC | 86877M209 | COM | 3,877,895 | $25,439,000 | thousands by filing date | |
| KEROS THERAPEUTICS INC COM | 492327101 | Stock | 672,306 | $25,218,000 | thousands by filing date | |
| VAXART INC NEW | 92243A200 | COM | 2,765,000 | $24,470,000 | thousands by filing date | |
| MYOVANT SCIENCES LTD | G637AM102 | COMMON STOCK-FO | 845,000 | $17,424,000 | thousands by filing date | |
| MARINUS PHARMACEUTICALS INC | 56854Q101 | COM | 5,726,540 | $14,545,000 | thousands by filing date | |
| INARI MED INC | 45332Y109 | COM | 235,000 | $11,383,000 | thousands by filing date | |
| KURA ONCOLOGY INC COM | 50127T109 | Stock | 575,000 | $9,373,000 | thousands by filing date | |
| SYNDAX PHARMACEUTICALS INC | 87164F105 | COM | 625,710 | $9,273,000 | thousands by filing date | |
| AVADEL PHARMACEUTICALS, PLC | 05337M104 | COMMON STOCK-FO | 1,057,827 | $8,547,000 | thousands by filing date | |
| ADAPTIMMUNE THERAPEUTICS PLC | 00653A107 | SPONDS ADR | 781,940 | $7,827,000 | thousands by filing date | |
| 89BIO INC | 282559103 | COM | 291,140 | $5,802,000 | thousands by filing date | |
| SIERRA ONCOLOGY INC | 82640U404 | CMN | 378,888 | $4,585,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001104659-20-095569 | this filing | 2020-08-14 | acceptance time not in the bulk data set |